News: Urologic Cancers

Next Page »

Cancer survival improvements vary by age, race

Thursday, February 26th, 2015

Improvements in cancer diagnosis and treatment have led to longer survival for most cancer patients in the United States. However, the improvement in survival was substantially greater among younger patients and those who are white in most of the cancers studied, according to new research by Vanderbilt University investigators. The study was published online recently […]

Grant bolsters Kirschner’s prostate cancer research

Thursday, February 5th, 2015

Austin Kirschner, M.D., Ph.D., assistant professor of Radiation Oncology and Cancer Biology, has received the Urology Care Foundation Research Scholars Award for the study of advanced prostate cancer. “I am very honored to receive this important award in support of research to help men with difficult-to-treat forms of prostate cancer,” said Kirschner, who joined the […]

New options enhance prostate cancer treatment

Thursday, January 29th, 2015

Vanderbilt-Ingram Cancer Center (VICC) patient William Ostman smiled while gazing into a camera lens and declared, “I am a prostate cancer survivor.” Ostman, 63, who now lives in Hermitage, Tennessee, was sharing his story recently in a video for the nonprofit organization ZERO – The End of Prostate Cancer. The fact that he is still […]

Potential Prostate Cancer Blood Test

Tuesday, January 6th, 2015

Vanderbilt University researcher William Mitchell, M.D., Ph.D., and colleagues in Germany and Canada have demonstrated a method for detecting “cell-free” tumor DNA in the bloodstream.

Key to Prostate Cancer Resistance

Friday, October 31st, 2014

Findings suggest a combination of therapies that may be effective in treating resistant prostate cancers

Penson to Lead Urologic Surgery

Thursday, September 11th, 2014

David Penson, M.D., will become chair of Vanderbilt’s Department of Urologic Surgery, effective Jan. 1, 2015.

New Fluorescing Agent Helps “Light up” Bladder Cancer

Monday, March 4th, 2013

Two urologic surgeons at Vanderbilt-Ingram Cancer Center are among a leading group of cancer physicians using an innovative new imaging agent and blue light system to “light up” cancerous cells inside the bladder. The combined system is used to confirm non-invasive papillary cancer inside the bladder and help surgeons detect and remove more of the […]

On the Hunt for Bladder Cancer Factors

Thursday, July 26th, 2012

Nearly 15,000 people in the United States die each year from metastatic bladder cancer. Signaling pathways that cause bladder tumor recurrence and spread are not clear. David DeGraff, Ph.D., a post-doctoral fellow in Urologic Surgery, and a multi-disciplinary team of colleagues including basic scientists, clinical pathologists and urologic surgeons, examined the role of the transcription […]

VICC to Host NCCN 2012 Congress Series

Wednesday, July 11th, 2012

Earn up to 5.5 continuing education credits! Program Overview: This congress is a full-day educational program designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Bladder, Kidney, and Prostate Cancers. Participants will learn how to implement the NCCN Guidelines recommendations into their […]

Going for the Gold

Tuesday, April 17th, 2012

Vanderbilt-Ingram Cancer Center cordially invites you and your guests to join us for Going for the Gold: Living Well through Cancer! Due to an overwhelming response, we have closed registration. We are thrilled to have so many people attend! Date: Saturday, June 30, 2012 Time: 9:30 a.m.-2:30 p.m. Where: Vanderbilt University Student Life Center 310 […]